StockData
First Tracks Biotherapeutics, Inc. logo

First Tracks Biotherapeutics, Inc. (TRAX) stock

TRAXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 3, 2026
$48.70−1.83 (-3.62%)

Close on Nov 12, 2026Market cap $1.74BP/E –Yield –

First Tracks Biotherapeutics statistics

37 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$1.74B
$280.48M
Enterprise Value
$1.58B
$148.62M
PB Ratio
11.52
2.05
P/TBV Ratio
11.52
2.29

Share statisticsIndustry

Shares Change (QoQ)
1.45%
0.51%
Float
35M
49M
Shares Held by Insiders
1.89%
12.1%
Shares Held by Institutions
92.0%
56.4%

Short sellingIndustry

Short Interest
5M
–
Short Interest Change
-27.3%
-0.76%
Short % of Float
14.4%
9.04%
Short % of Shares Outstanding
14.2%
6.30%
Days to Cover
6.52
5.13

Stock price statisticsIndustry

20-Day Moving Average
$45.09
–
50-Day Moving Average
$39.81
–
Average True Range (14)
$3.42
–
Price Change (1 Week)
7.20%
1.51%
Price Change (1 Month)
42.7%
-2.35%
Price Change (3 Months)
10.6%
-21.1%
Price Change (6 Months)
168.2%
-22.6%
Average Volume (10 Days)
613,003
–
Average Volume (20 Days)
718,417
–
Average Volume (90 Days)
866,586
–
Relative Volume
0.36
0.79
Relative Strength Index (14)
60.6
44.7
Volatility (1 Year)
123.1%
80.4%

Financial positionIndustry

Current Ratio
9.16
3.30
Quick Ratio
8.60
2.42

Balance sheetIndustry

Net Cash (Debt)
$155.63M
$17.46M
Net Cash Per Share
$4.36
$0.72
Equity (Book Value)
$151.01M
$53.27M
Book Value Per Share
$4.23
$1.50
Tangible Book Value
$151.01M
$26.82M
Working Capital
$147.63M
$79.47M

Scores and fair valueIndustry

Altman Z-Score
54.27
0.30

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodTRAXS&P 500DifferenceTRAX per yearS&P 500 per year
1 month+43.0%-2.7%+45.7 pts
3 months+5.6%-1.7%+7.3 pts

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M TRAX shares were sold short on Oct 30, 2026, down 27.3% from the previous report, or 14.42% of the shares available to trade. At recent volumes it would take 6.5 days to buy them back. Over the last 20 sessions, 46.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 20265,056,413-27.3%775,0676.5
Oct 15, 20266,958,100+34.0%1,456,0794.8
Sep 30, 20265,190,809+15.3%837,9886.2
Sep 15, 20264,500,079+11.7%599,9777.5
Aug 31, 20264,030,463+3.5%556,6857.2
Aug 14, 20263,892,563-1.6%576,5086.8
Jul 31, 20263,957,023-17.1%854,1614.6
Jul 15, 20264,771,705+22.0%1,137,7164.2
Jun 30, 20263,912,589+33.2%818,1824.8
Jun 15, 20262,936,884-24.2%574,2365.1
May 29, 20263,873,888-1.1%372,28110.4
May 15, 20263,916,597-2.8%478,3688.2

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?